Serum soluble urokinase-type plasminogen activator receptor (suPAR) levels in male patients with acute exacerbation of schizophrenia

被引：0
|
作者：
Genc, A. [1 ]
Kalelioglu, T. [2 ]
Karamustafalioglu, N. [2 ]
Tasdemir, A. [3 ]
Genc, E. Sena [2 ]
Akkus, M. [2 ]
Emul, M. H. [4 ]
机构：
[1] Sisli Etfal Educ & Res Hosp, Psychiat, Istanbul, Turkey
[2] Bakirkoy Res & Training State Hosp, Psychiat, Istanbul, Turkey
[3] Samsun Mental & Neurol Hlth Hosp, Psychiat, Samsun, Turkey
[4] Istanbul Univ, Psychiat, Cerrahpasa Med Sch, Istanbul, Turkey
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2015年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.1.f.013
引用
收藏
页码：S232 / S233
页数：2
相关论文
共 50 条
  • [31] Evaluation of soluble urokinase-type plasminogen activator receptor (suPAR) quick test for triage in the emergency department
    Kumar, Pratyush
    Kakar, Atul
    Gogia, Atul
    Waziri, NIamatullah
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2019, 8 (12) : 3871 - 3875
  • [32] Assessment of Serum Levels of Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Patients with Periodontitis and Atheroscletotic Cardiovascular Disease
    Hamad, Safa Ali
    Mahmood, Maha Shukri
    JOURNAL OF RESEARCH IN MEDICAL AND DENTAL SCIENCE, 2022, 10 (02): : 719 - 723
  • [33] Soluble urokinase-type plasminogen activator receptor (SuPAR) in patients with Parkinsons disease (P1-1.Virtual)
    Witek, Natalie
    Joyce, Jessica
    Patel, Roshni
    Hawkins, Jacob
    Liu, Yuanqing
    Ouyang, Bichun
    Borgia, Jeffrey
    Jochen, Reiser
    Hall, Deborah
    NEUROLOGY, 2022, 98 (18)
  • [34] Hyperglycemia is associated with lower levels of urokinase-type plasminogen activator and urokinase-type plasminogen activator receptor in wound fluid
    Akinci, Bans
    Terzi, Cem
    Sevindik, Gokmen
    Yuksel, Faize
    Tunc, Ulku Aybuke
    Tunali, Sunay
    Yesil, Sena
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2014, 28 (06) : 844 - 849
  • [35] Evaluation of plasma urokinase-type plasminogen activator and urokinase-type plasminogen-activator receptor in patients with acute and chronic hepatitis B
    Zhou, Huanqin
    Wu, Xianguo
    Lu, Xingguo
    Chen, Gang
    Ye, Xiongwei
    Huang, Jian
    THROMBOSIS RESEARCH, 2009, 123 (03) : 537 - 542
  • [36] Sex Differences in Circulating Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels and Adverse Outcomes in Coronary Artery Disease
    Mehta, Anurag
    Desai, Shivang R.
    Ko, Yi-An
    Liu, Chang
    Dhindsa, Devinder S.
    Nayak, Aditi
    Hooda, Ananya
    Martini, Mohamed A.
    Ejaz, Kiran
    Sperling, Laurence S.
    Reiser, Jochen
    Hayek, Salim S.
    Quyyumi, Arshed A.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (05):
  • [37] Soluble urokinase plasminogen activator receptor (suPAR) levels in healthy pregnancy and preeclampsia
    Toldi, Gergely
    Biro, Edina
    Szalay, Balazs
    Stenczer, Balazs
    Molvarec, Attila
    Rigo, Janos, Jr.
    Vasarhelyi, Barna
    Beko, Gabriella
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (11) : 1873 - 1876
  • [38] The diagnostic value of serum urokinase-type plasminogen activator receptor in acute appendicitis
    Aygun, Ali
    Gunaydin, Mucahit
    Ozozan, Omer Vefik
    Cihan, Murat
    Karakahya, Murat
    ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY, 2019, 25 (05): : 467 - 473
  • [39] The Relationship Between Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels and Treatment Response in Patients With Glomerulonephritis: A Single-Center Experience
    Issever, Kubilay
    Dheir, Hamad
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
  • [40] Soluble Urokinase-Type Plasminogen Activator Receptor and Arterial Stiffness in Patients with COPD
    Renáta M. Böcskei
    Béla Benczúr
    György Losonczy
    Miklós Illyés
    Attila Cziráki
    Veronika Müller
    Anikó Bohács
    András Bikov
    Lung, 2019, 197 : 189 - 197
12345